Lamivudine therapy for chronic hepatitis B: A six-month randomized dose- ranging study

Gastroenterology

Volumn 113, Issue 4, 1997, Pages 1258-1263

  Nevens, F ^a   Main, J ^a   Honkoop, P ^a   Tyrrell, D L ^a   Barber, J ^a   Sullivan, M T ^a   Fevery, J ^a   De Man, R A ^a   Thomas, H C ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; LAMIVUDINE; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL TOXICITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN TOXICITY; TREATMENT OUTCOME; VIRUS HEPATITIS; VIRUS REPLICATION;

EID: 0030772798     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.1997.v113.pm9322520     Document Type: Article

References (17)